Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    Open Studies | "Acromegaly"
Show Display Options
Rank Status Study
21 Not yet recruiting Dynamic Hormone Diagnostics in Endocrine Disease
Conditions: Adrenal Insufficiency;   Congenital Adrenal Hyperplasia;   Cushing Syndrome;   Growth Hormone Deficiency;   Acromegaly;   Primary Hyperaldosteronism
Intervention: Other: 27 hour subcutaneous fluid sampling
22 Recruiting Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Conditions: Cushing's Disease;   Acromegaly;   Neuroendocrine Tumors;   Pituitary Tumors;   Ectopic ACTH Secreting (EAS) Tumors;   Dumping Syndrome;   Prostate Cancer;   Melanoma Negative for bRAF;   Melanoma Negative for nRAS
Intervention: Drug: Pasireotide
23 Recruiting PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
Condition: Pituitary Tumor
Intervention:
24 Recruiting Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Condition: Pituitary Tumours
Intervention: Procedure: Gallium-68 DOTATOC PET

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-24) Next Page   
Study has passed its completion date and status has not been verified in more than two years.